Prevalence, incidence, and screening for geriatric conditions among people aging with HIV in the united states
Active Grant Awarded
- Award ID
- R21AG102217
- Recipient
-
The University Of Chicago UEI ZUE9HKT2CLC9
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $205,000
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date 12% complete
- Funding agency
- National Insititue of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health, Department of Health and Human Services
- Place of performance
- Chicago, IL 60637, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded The University of Chicago a grant totaling $205,000 on September 9, 2026, under Assistance Listing 93.846, Arthritis, Musculoskeletal and Skin Diseases Research. Grant R21AG102217 funds research into the prevalence, incidence, and screening for geriatric conditions among people aging with HIV in the United States. Work is performed in Chicago, Illinois 60637, and the full $205,000 is obligated against an ultimate completion date of May 31, 2028.
Aim 1 uses nationwide Medicaid and Medicare data to measure prevalence, incidence, and age of onset of frailty, polypharmacy, cognitive impairment, and multimorbidity among people with HIV, compared with matched HIV-negative beneficiaries. The project also examines trajectories in severity of frailty and cognitive impairment over time in people with HIV versus those without HIV. A survey of Ryan White HIV clinics addresses geriatric syndrome screening and management practices, with the goal of identifying the frequency and age at which screening should begin.
Description
- Abstract
- Older people with HIV (OPWH) ages 50 and older now account for more than 50% of PWH in the united states following advances in antiretroviral therapy (art) that have increased life expectancy. With this shift, PWH are increasingly impacted by geriatric syndromes that affect quality of life and potentially HIV care outcomes. These geriatric syndromes can appear earlier in PWH than in the general population since HIV has been associated with premature aging. Nonetheless, many questions about geriatric syndromes among people living with HIV (PWH) remain, including the current prevalence, incidence, and age of geriatric syndrome onset, as well as current practices in screening for these syndromes. This proposal seeks to answer existing questions for a subset of syndromes in the 5MS of geriatric care: frailty (MOBILITY), polypharmacy (MEDICATIONS), cognitive impairment (MENTATION), and multimorbidity among PWH who are enrolled in medicaid and medicare, as well as by surveying ryan white HIV clinics regarding geriatric syndrome screening and management. In aim 1, we will use nationwide medicaid and medicare data to identify the prevalence, incidence, and incident age of these geriatric syndromes among PWH compared to comparable matched HIV-negative beneficiaries. We will also identify a subset of the PWH newly diagnosed with frailty, polypharmacy, cognitive impairment, and multimorbidity, allowing US to report the incidence of these syndromes and to identify the age of disease onset in PHW compared to their matched HIV-negative controls. Additionally, we will examine trajectories in severity of frailty and cognitive impairment over time among PWH compared to those without HIV. This aim will provide important information on how common these syndromes are among PWH, and to identify the frequency and age to begin screening for these geriatric syndromes. In aim 2, we will assess the impact these geriatric syndromes have on HIV related care, including retention in care and adherence to art, compared to PWH who are age, program (medicaid or medicare), and enrollment length matched controls without these geriatric syndromes. In aim 3, we will assess the current environment for geriatric syndrome screening and management for PWH who receive care at ryan white-funded clinics by administering a survey to staff to understand current screening practices for geriatric syndromes, tools used in screening, barriers to geriatric syndrome screening and management, and referral pathways to specialty care for these syndromes. This research will contribute to understanding how common frailty, polypharmacy, cognitive impairment, and multimorbidity are among PWH. Importantly, this project will provide information regarding the optimal age to start screening, and how often screening should be performed, as well as if these geriatric syndromes impact retention and adherence HIV care outcomes. Finally, we will understand the landscape of geriatric syndrome screening in ryan white-funded clinics and barriers to implementation in these settings to inform future work.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $204,999 | |
| Original award | $1 |
Quick answers
Who received award R21AG102217?
R21AG102217 was awarded to The University Of Chicago by National Institute on Aging (National Institutes of Health) on September 9, 2026.
How much is award R21AG102217 worth?
$205,000 has been obligated on R21AG102217.
Which agency awarded R21AG102217?
National Institute on Aging (National Institutes of Health) awarded R21AG102217, with funding from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award